Mixed Phenotypic Acute Leukemia (mixed myeloid/B-cell) with Myeloid Sarcoma of the Thyroid Gland: A Rare Entity with Rarer Asssociation - Detected on FDG PET/CT

Mixed phenotypic acute leukemia (MPAL) is a rare clinical entity. MPAL associated with myeloidsarcoma (MS) is still rarer with only three cases mentioned in English literature. MS has been described in myriads of location, most commonly in skin, gums and lymph nodes. Although theoritically possible, it is very rare to find MS involving the thyroid gland. The diagnosis of MS can be elusive, very often masquerades and mislabeled as lymphoma. A high index of clinical suspicion coupled with PET/CT findings along with morphological clues and thorough peripheral blood, and bone marrow evaluation is mandatory for arriving at the definitive diagnosis. We report the case of a 58-year-old female presenting with thyroid swelling that was subsequently diagnosed to be MS of the thyroid with underlying MPAL (mixed myeloid/B-cell) only after 18F-FDG PET/CT, which revealed an unusual abnormal pattern of multifocal intense FDG uptake in the thyroid gland.

[1]  J. Newman,et al.  Primary granulocytic sarcoma of larynx , 2015, Head & neck.

[2]  A. Alizadeh,et al.  Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria. , 2014, American journal of clinical pathology.

[3]  M. Dababo,et al.  Lateral pharyngeal wall myeloid sarcoma as a relapse of acute biphenotypic leukemia: a case report and review of the literature , 2013, Journal of Medical Case Reports.

[4]  M. Anthony,et al.  Utility of FDG PET/CT in the assessment of myeloid sarcoma. , 2012, AJR. American journal of roentgenology.

[5]  B. Avni,et al.  Myeloid sarcoma: current approach and therapeutic options , 2011, Therapeutic advances in hematology.

[6]  G. Ehninger,et al.  18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia , 2011, Haematologica.

[7]  Rong-Sen Yang,et al.  Prognostic Factors of Treatment Outcomes in Patients with Granulocytic Sarcoma , 2009, Acta Haematologica.

[8]  N. Akyürek,et al.  Granulocytic sarcoma after stem cell transplantation in a child with biphenotypic leukemia. , 2009, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[9]  Jianmin Yang,et al.  Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population , 2009, Haematologica.

[10]  Y. Ning,et al.  Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study , 2007, Diagnostic pathology.

[11]  G. Tekuzman,et al.  Granulocytic sarcoma of the urinary bladder , 2004, American journal of hematology.

[12]  D. Grimwade,et al.  Extramedullary disease in acute promyelocytic leukemia. , 1999, Leukemia & lymphoma.

[13]  K. Seiter,et al.  Biphenotypic (mixed myeloid/T-cell) extramedullary myeloid cell tumor. , 1999, Leukemia & lymphoma.

[14]  R. Sen,et al.  Chloroma of Perianal Region Masquerading as Perianal Abscess , 2013, Indian journal of dermatology.